Half of the patients who received an experimental vaccine for pancreas cancer being developed by Roche and BioNTech following ...

The new center will be a hub for both Roche and Genentech, bringing together expertise in Cardiovascular, Renal, and ...

Quantum Strategy's David Roche says Europe's defense spending needs to increase by at least $200 billion as he discusses the ...

Though David says his ankle weights warmup is “unscientific” and does not recommend this practice to the athletes he coaches, ...

According to Roche subsidiary Genentech, which announced the label expansion on Monday, TNKase is the first new drug for ...

Roche's Q4 results and innovative advancements make it a strong pick. Its late-stage pipeline supports our belief that there ...

Conor and Ian Roche have worked together on nearly two dozen surgeries in the operating room at Altru Hospital.

The changes at Spark follow Roche's decision last year to halt development of a gene therapy for hemophilia A that was the ...

Illumina navigates competition and geopolitical risks with improved margins and strong cash flow. Read my analysis of ILMN ...

Posay, the dermatologist-recommended leader in skincare, is thrilled to announce its partnership with the BNP Paribas Open as ...

The value that laboratories contribute to clinical decision-making is critical to the future of health care and enables ...

Submission is supported by positive results from the Phase III REGENCY trial, which demonstrated that nearly half of patients ...